Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
CING
CING News & Events
-
Add to Watchlist
Trade CING
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
CING News
Cingulate Reports Slight Increase in Q4 Net Loss
Mar 18 2026
seekingalpha
Cingulate's ADHD Drug Patent Approved by USPTO
Mar 16 2026
stocktwits
Biotech Stocks Surge: Coherus Up 9.09% in After-Hours Trading
Jan 23 2026
NASDAQ.COM
Roth Capital Reaffirms Buy Rating on Cingulate, Reduces Price Target to $16
Nov 19 2025
Benzinga
INBX Rises 81% Following Study Results; FEMY, CING, CYH Surge in After-Hours Trading
Oct 24 2025
NASDAQ.COM
Cingulate's Top ADHD Candidate CTx-1301 Chosen for Podium Presentation at AACAP Annual Meeting
Oct 23 2025
Newsfilter
Roth Capital Reaffirms Buy Rating on Cingulate, Increases Price Target to $17
Oct 15 2025
Benzinga
Cingulate Forms Exclusive Manufacturing Alliance with Bend Bio Sciences for Upcoming ADHD Treatment Commercialization
Sep 17 2025
Newsfilter
Show More News
CING Events
04/14 17:30
Cingulate Files to Sell 4.21M Shares of Common Stock
Cingulate files to sell 4.21M shares of common stock for holders
03/20 07:50
Cingulate Files to Sell 3.5M Shares of Common Stock
Cingulate files to sell 3.5M shares of common stock for holders
Show More Events
CING Monitor News
No data
CING Earnings Analysis
No Data
People Also Watch
